JO

Journal of Immunotherapy

Journal of Immunotherapy is a journal focused on immunotherapy research and clinical studies in oncology and related areas. It publishes 9 issues per year and lists rankings in Oncology, Immunology, and Medicine, Research, and Experimental, with an Impact Factor of 2.9.

Looking to publish in Journal of Immunotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Immunology, Medicine, Research & Experimental, Oncology
Impact Factor 2.9
Quartile Q3
Open Access Type Hybrid
ISSN 1524-9557
eISSN 1537-4513
Invitation Only No
Cost Range Open access APC is charged on acceptance and must be paid within 30 days; pricing is provided on the Wolters Kluwer Open Health Journals list.

Submission Instructions

Journal of Immunotherapy accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover Letter requirements are not specified.
Abstract An unstructured abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured.
Manuscript Text must be organized under the four main headings Introduction, Materials and Methods, Results, and Discussion. Manuscript must include three to five key words or phrases, a conflicts and funding statement on the title page, an acknowledgments paragraph for support, and AI-use disclosures in the Materials and Methods or a similar section when applicable.
References References must follow the American Medical Association Manual of Style, 9th edition. References must be cited in the text in order of appearance, and for works with more than three authors only the first three authors should be listed followed by et al.
Figures & Tables Figures must be submitted as separate files rather than embedded in the manuscript, figure legends must appear on a separate page after the text, and each table must appear on a separate page rather than within the manuscript body. Figures and tables must be cited consecutively in the text, legends are required for figures, and each table must include a title, appropriate column heads, and explanatory legends including definitions of abbreviations.
Reformat to Journal of Immunotherapy using Livewrite Premium

Basic Studies

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words. Abstract must be unstructured.
Manuscript Text must be organized under the headings Introduction, Materials and Methods, Results, and Discussion. Manuscript must include three to five keywords or phrases, conflict-of-interest and funding disclosures on the title page, an acknowledgments paragraph for support, and AI-use disclosure in the Materials and Methods or similar section when applicable.
References References must follow the American Medical Association Manual of Style, 9th edition. References must be cited in order of appearance, and if a reference has more than three authors only the first three should be listed followed by et al.
Figures & Tables Figures must be uploaded as separate files and not embedded in the manuscript text file, and each table must appear on a separate page and not be embedded within the body of the manuscript. Figures and tables must be cited consecutively in the text, each figure must have a legend on a separate manuscript page after the text, and each table must include a title, column heads, and explanatory legends with abbreviations defined.
Reformat to Journal of Immunotherapy using Livewrite Premium

Clinical Studies

Cover Letter Cover Letter requirements are not specified.
Abstract An unstructured abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured.
Manuscript Text must be organized under the main headings Introduction, Materials and Methods, Results, and Discussion. Manuscript must include three to five keywords or phrases and must disclose any use of AI tools in the Materials and Methods or a similar section, specifying how the tool was used and which tool was used.
References References must follow the American Medical Association Manual of Style, 9th edition. References must be cited in the text in order of appearance, and for works with more than three authors only the first three authors should be listed followed by et al.
Figures & Tables Figures must be submitted as separate files rather than embedded in the manuscript, and tables must not be embedded within the body of the manuscript. Legends must be provided for all figures on a separate manuscript page after the text, and each table must appear on a separate page with a title, column heads, and explanatory legends including definitions of abbreviations.
Reformat to Journal of Immunotherapy using Livewrite Premium

Brief Communication

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured.
Manuscript Manuscript must not exceed 1500 words. Title must include the phrase "Brief Communication." Manuscript must include three to five key words or phrases, and any use of AI tools must be disclosed in the Materials and Methods or a similar section.
References References must not exceed 15. References must follow American Medical Association Manual of Style, 9th edition. References must be cited in the text in order of appearance, and for works with more than three authors only the first three authors should be listed followed by et al.
Figures & Tables Figures and tables must not be embedded in the manuscript text, with figures submitted as separate files and each table placed on a separate page. Each figure must have a brief, specific legend on a separate manuscript page after the text, and each table must include a title, appropriate column heads, and explanatory legends.
Reformat to Journal of Immunotherapy using Livewrite Premium

Case Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 2000 words long. Manuscript must include Title page including author details, Abstract, Case presentation, Discussion, References, and Figures (optional), and it must include an up-to-date review of previous cases in the field. Manuscript must list three to five key words or phrases, include conflict-of-interest and funding disclosures on the title page, and disclose AI use in the Materials and Methods or a similar section.
References References are limited to up to 10. References must follow the American Medical Association Manual of Style, 9th edition. References must be cited in the text in order of appearance, and for works with more than three authors only the first three authors should be listed followed by et al.
Figures & Tables Case Reports may include no more than 3 figures. Figures must be submitted as separate files and must not be embedded in the manuscript text file, and tables must not be embedded within the body of the manuscript. Figure legends must be provided on a separate manuscript page after the text, and each table must appear on a separate page with a title, column heads, and explanatory legends.
Reformat to Journal of Immunotherapy using Livewrite Premium

Recent Publications

Auranofin Sensitizes Oral Squamous Cell Carcinoma to PD-1 Blockade Through DUSP1-Associated Macrophage Reprogramming

Lixia Zhang, Camyla R. Nascimento, William J. Magner, Scott I. Abrams, Keith L. Kirkwood

10.1097/cji.0000000000000621
View Publication

Immune Checkpoint Inhibitors After Chemoradiation in Unresectable Non–Small Cell Lung Cancer: Survival Outcomes From a Tertiary Care Center in Lebanon

Hasan Numan, Sacha El Khoury, Zeinab Dandash, Bassem Youssef, Arafat Tfayli, Malek Safa

10.1097/cji.0000000000000626
View Publication

Association Between Neoadjuvant Immunochemotherapy Efficacy and Pathologic Characteristics in dMMR Gastric/Gastroesophageal Junction Adenocarcinoma

Yong Wang, Rui Zhao, Qian Yi Wan, Jing Ru Li, Zhen Jie Dai, Yong Zhou, Jing Chen

10.1097/cji.0000000000000625
View Publication

Immunostaining of p53 Is Associated With Efficacy of Anti-PD-1 Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ming-Chun Kuo, Tai-Lin Huang, Tai-Jan Chiu, Wan-Ting Huang, Tsung-Han Tsai, Shau-Hsuan Li

10.1097/cji.0000000000000624
View Publication

Erratum: Integrating Bulk RNA-Seq and Spatial Transcriptomics Data to Reveal Distinct Immune Escape Mechanism and Immunotherapy Based on Post-Translational Modification in Head and Neck Squamous Cell Carcinoma

Kai Li, Chuyi Cai, Qingmei Chen, Danhua Hu

10.1097/cji.0000000000000619
View Publication

Frequently asked questions

How long does it take to publish?

Open access APC is charged on acceptance and must be paid within 30 days. Proof corrections must be returned within 24 to 48 hours of receipt. Reprints are normally shipped 6 to 8 weeks after publication.

Reformat to Journal of Immunotherapy using Livewrite Premium

Is a cover letter required?

A cover letter accompanies page proofs. Manuscript submission requires online submission through Editorial Manager and signed authorship, disclosure, and copyright forms.

Reformat to Journal of Immunotherapy using Livewrite Premium

What are the publication costs?

Hybrid open access publishing is available.

Reformat to Journal of Immunotherapy using Livewrite Premium

Research Topics

Immunotherapy and Immune Responses CAR-T cell therapy research Cancer Immunotherapy and Biomarkers Immune Cell Function and Interaction Monoclonal and Polyclonal Antibodies Research T-cell and B-cell Immunology Virus-based gene therapy research RNA Interference and Gene Delivery vaccines and immunoinformatics approaches Cancer Research and Treatments Immune cells in cancer Radiopharmaceutical Chemistry and Applications Lymphoma Diagnosis and Treatment Glycosylation and Glycoproteins Research Immune Response and Inflammation Toxin Mechanisms and Immunotoxins Cytomegalovirus and herpesvirus research Cytokine Signaling Pathways and Interactions Chronic Lymphocytic Leukemia Research Neuroblastoma Research and Treatments Lung Cancer Treatments and Mutations Chemokine receptors and signaling Renal cell carcinoma treatment Colorectal Cancer Treatments and Studies Cancer Cells and Metastasis

Related Journals

MC
Molecular Cancer Research American Association for Cancer Research
IJ
International Journal of Clinical Oncology Springer Science+Business Media
CS
Clinical Science Portland Press
FI
Frontiers in Cellular and Infection Microbiology Frontiers Media
Im
Immunity CELL PRESS
MA
Molecular Aspects of Medicine Elsevier BV